Patent · US Active

Low anticoagulant heparins

US9480701B2 · kind B2 · utility

0Cited by

13References

29Claims

0Family size

Assignee

DILAFORETTE AB · SE

Inventors

Hans-Peter Ekre · Stockholm, SE
Ulf Lindahl · Uppsala, SE
Erik Holmer · Stockholm, SE
Per-Olov Eriksson · Hagfors, SE
Anna Leitgeb · Hallsberg, SE
Mats Wahlgren · Stocksund, SE
Stefania Tiddia · Modena, IT
Lino Liverani · Faenza, IT

Key dates

Filing date	Dec 19, 2012
Grant date	Nov 1, 2016
Priority date	—
Expiry date	Dec 19, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a chemically modified heparin, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Also disclosed is a method of preparing the heparin and its medical use, including treatment of malaria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.